Important safety information Prescribing Information
Chemistry
Chemistry

*Individual results may vary. In clinical trials of over 1000 subjects, approximately 30% were clear or almost clear (IGA) by week 12 with a 70% median inflammatory lesion count reduction from baseline.

Important Safety Information for Epiduo® (adapalene and benzoyl peroxide) Gel 0.1%/2.5%

Epiduo® Gel is a retinoid and antimicrobial combination product indicated for the topical treatment of acne vulgaris in patients 12 years and older. The most common adverse events associated with use of Epiduo® Gel are erythema, scaling, dryness, stinging and burning. In addition, in clinical trials, adverse events reported in greater than 1% of patients treated with the Gel included contact dermatitis and skin irritation. Excessive exposure to sunlight and sunlamps should be avoided during treatment, and use of sunscreen products and protective clothing is recommended. Concomitant use of irritating topical products (like products containing resorcinol, salicylic acid or sulfur) should be avoided. Instruct patients to avoid the eyes, lips and mucous membranes when applying Epiduo® Gel. Epiduo® Gel has not been tested in pregnant or nursing women, or with the elderly. Pregnancy Category C. Please see full Prescribing Information.

product samples

REQUEST SAMPLES
Call 1-888-786-5510 to check your eligibility to receive
samples of Epiduo® Gel. Use reference code: MKTEPIDUO.

section divider Check Formulary Status

Review formulary coverage for Epiduo® Gel in your state.

Check Formulary Status
This site is intended for U.S. healthcare professionals only.
Are you a healthcare professional?
Sign in or register to
access this exclusive
content and to gain
future access to:
Log in for exclusive physician resources.

Email:
Password:
Not registered? Get access now
Forgot your password? Click here